Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome

References

• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448–54.
   PubMed Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003;107:499–511.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391–97.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 2004;114:1752–61.
   PubMed Web of Science ®Google Scholar
• Sankhla M, Sharma TK, Mathur K, Rathor JS, Butolia V, Gadhok AK, et al. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clinical Laboratory 2012;58:385–92.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005;352: 1685–95 + 26.
   PubMed Web of Science ®Google Scholar
• Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000;87:840–44.
   PubMed Web of Science ®Google Scholar
• Czernichow S, Greenfield JR, Galan P, Jellouli F, Safar ME, Blacher J, et al. Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertension Research: Official Journal of the Japanese Society of Hypertension 2010;33:293–97.
   PubMed Web of Science ®Google Scholar
• Gyawali P, Richards RS, Hughes DL, Tinley P. Erythrocyte aggregation and metabolic syndrome. Clinical Hemorheology and Microcirculation 2014;57:73–83.
   PubMed Web of Science ®Google Scholar
• Gyawali P, Richards RS, Nwose EU. Erythrocyte morphology in metabolic syndrome. Expert Review of Hematology 2012;5:523–31.
   PubMed Web of Science ®Google Scholar
• Gyawali P, Richards RS, Nwose EU, Bwititi PT. Whole-blood viscosity and metabolic syndrome. Clinical Lipidology 2012;7:709–19.
   Web of Science ®Google Scholar
• Gyawali P, Richards RS, Tinley P, Nwose EU. Hemorheology, ankle brachial pressure index (abpi) and toe brachial pressure index (tbpi) in metabolic syndrome. Microvascular Research 2014;95:31–36.
   PubMed Web of Science ®Google Scholar
• Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Seminars in the Thrombosis and Hemostasis 2003;29:435–50.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith C Jr, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation 2004;109:433–38.
   PubMed Web of Science ®Google Scholar
• Hou JX, Shin S. Transient microfluidic approach to the investigation of erythrocyte aggregation: comparison and validation of the method. Korea–Australia Rheology Journal 2008;20:253–60.
   Web of Science ®Google Scholar
• Baskurt OK, Hardeman MR, Uyuklu M, Ulker P, Cengiz M, Nemeth N, et al. Parameterization of red blood cell elongation index – shear stress curves obtained by ektacytometry. Scandinavian Journal of Clinical and Laboratory Investigation 2009;69:777–88.
   PubMed Web of Science ®Google Scholar
• Simmonds MJ, Minahan CL, Serre KR, Gass GC, Marshall-Gradisnik SM, Haseler LJ, et al. Preliminary findings in the heart rate variability and haemorheology response to varied frequency and duration of walking in women 65–74 yr with type 2 diabetes. Clinical Hemorheology and Microcirculation 2012;51:87–99.
   PubMed Web of Science ®Google Scholar
• Nwose EU, Richards RS, McDonald S, Jelinek HF, Kerr PG, Tinley P. Assessment of diabetic macrovascular complications: a prediabetes model. British Journal of Biomedical Science 2010;67:59–66.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997;82:291–95.
   PubMed Web of Science ®Google Scholar
• Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sciences 2009;84:705–12.
   PubMed Web of Science ®Google Scholar
• Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. The Journal of Nutritional Biochemistry 2008;19:491–504.
   PubMed Web of Science ®Google Scholar
• Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. The role of erythrocytes in the inactivation of free radicals. Medical Hypotheses 1998;50:363–67.
   PubMed Web of Science ®Google Scholar
• Lynch RE, Fridovich I. Permeation of the erythrocyte stroma by superoxide radical. Journal of Biological Chemistry 1978;253:4697–99.
   PubMed Web of Science ®Google Scholar
• Salo DC, Lin SW, Pacifici RE, Davies KJ. Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide. Free Radical Biology & Medicine 1988;5:335–39.
   PubMed Web of Science ®Google Scholar
• Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. Journal of Pineal Research 2011;50:261–66.
   PubMed Web of Science ®Google Scholar
• Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Annals of Neurology 1992;32:S22–S27.
   PubMed Web of Science ®Google Scholar
• Tsai IJ, Croft KD, Mori TA, Falck JR, Beilin LJ, Puddey IB, et al. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radical Biology & Medicine 2009;46:263–70.
   PubMed Web of Science ®Google Scholar
• Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40:1286–92.
   PubMed Web of Science ®Google Scholar
• Sigdel M, Kumar A, Gyawali P, Shrestha R, Tuladhar ET, Jha B. Association of high sensitivity C-reactive protein with the components of metabolic syndrome in diabetic and non-diabetic individuals. Journal of Clinical and Diagnostic Research 2014;8:CC11–13.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Jha SC, Khanal M, Gyawali P, Yadav BK, Jha B. Association of cardiovascular risk factors in hypertensive subjects with metabolic syndrome defined by three different definitions. JNMA Journal of Nepal Medical Association 2011;51:157–63.
   PubMed Web of Science ®Google Scholar
• Fusman G, Mardi T, Justo D, Rozenblat M, Rotstein R, Zeltser D, et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. The American Journal of Cardiology 2002;90:561–63.
   PubMed Web of Science ®Google Scholar
• Richards RS, Nwose EU. Blood viscosity at different stages of diabetes pathogenesis. British Journal of Biomedical Sciences 2010;67:67–70.
   PubMed Web of Science ®Google Scholar
• Coppola L, Grassia A, Giunta R, Verrazzo G, Cava B, Tirelli A, et al. Glutathione (GSH) improved haemostatic and haemorheological parameters in atherosclerotic subjects. Drugs under Experimental and Clinical Research 1991;18:493–98.
   Google Scholar
• Kowalczyk E, Kowalski J, Błaszczyk J, Gwoździński L, Ciećwierz J, Sienkiewicz M. Estimation of cell membrane properties and erythrocyte red-ox balance in patients with metabolic syndrome. Molecular Biology Reports 2012:1–6.
   Google Scholar
• Yedgar S, Koshkaryev A, Barshtein G. The red blood cell in vascular occlusion. Pathophysiology of Haemostasis and Thrombosis 2002;32:263–68.
   PubMedGoogle Scholar
• Lowe GDO, Rumley A. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thrombosis and Haemostasis 1999;82:667–72.
   PubMed Web of Science ®Google Scholar
• Becatti M, Marcucci R, Bruschi G, Taddei N, Bani D, Gori AM, et al. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arteriosclerosis Thrombosis, and Vascular Biology 2014.
   PubMed Web of Science ®Google Scholar
• Martinez M, Weisel JW, Ischiropoulos H. Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots. Free Radical Biology & Medicine 2013;65:411–18.
   PubMed Web of Science ®Google Scholar
• Toth A, Papp J, Rabai M, Kenyeres P, Marton Z, Kesmarky G, et al. The role of hemorheological factors in cardiovascular medicine. Clinical Hemorheology and Microcirculation 2014;56:197–204.
   PubMed Web of Science ®Google Scholar
• Popel AS, Johnson PC. Microcirculation and hemorheology. Annual Review of Fluid Mechanics 2005;37:43.
   PubMed Web of Science ®Google Scholar